Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Identifying and researching key issues in the ageing haemophilia population

ADVANCE WORKING GROUP

The ADVANCE Working Group consists of experienced haemophilia treaters from across Europe who wish to raise awareness of issues related to the ageing haemophilia population and to consider how current management strategies should best be adapted to their needs.

 

Since its inception ADVANCE has developed recommendations and ongoing studies that aim to:

  • Highlight key issues associated with the ageing haemophilia population
  • Identify how management of age-related co-morbidities should be adapted to those with haemophilia
  • Encourage the development of further research focusing on the ageing haemophilia population
  • Generate recommendations that can be used by clinicians across Europe